Skip to main content

Vera Therapeutics, Inc.

VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001831828

In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Vera Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of VERA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders2231+9
Shares14.5M14.7M+197.4K (+1.4%)
Value$186.1M$252.4M+$66.3M (+35.6%)

New holders (16)

Institutions that held Vera Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to VERA in Q3 2021
InstitutionSharesValue% of portfolio
JPMorgan Chase & Co78,652$1.36M0.00%
State Street Corp75,255$1.31M0.00%
Northern Trust Corp59,315$1.03M0.00%
Gyon Technologies Capital Management, LP19,042$330.0K0.09%
Charles Schwab Investment Management Inc16,948$295.0K0.00%
Bank of New York Mellon Corp13,224$230.0K0.00%
Deutsche Bank AG4,068$71.0K0.00%
American International Group, Inc.3,867$67.0K0.00%
California State Teachers Retirement System3,817$66.0K0.00%
STRS Ohio1,600$27.0K0.00%
New York State Common Retirement Fund1,200$21.0K0.00%
Citigroup Inc810$14.0K0.00%
Royal Bank of Canada780$13.0K0.00%
Legal & General Group Plc662$12.0K0.00%
Tower Research Capital LLC (TRC)605$10.0K0.00%
Ameritas Investment Partners, Inc.542$9.00K0.00%

Sold out (7)

Institutions that held Vera Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of VERA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Millennium Management LLC81,452$1.08M
Monashee Investment Management LLC46,069$611.0K
Caas Capital Management LP20,000$265.0K
Maven Securities LTD13,000$178.0K
ExodusPoint Capital Management, LP12,841$170.0K
Goldman Sachs Group Inc11,747$156.0K
UBS Group AG956$13.0K